Linezolid resistant coagulase negative staphylococci (LRCoNS) with novel mutations causing blood stream infections (BSI) in India

Linezolid resistant coagulase negative staphylococci (LRCoNS) with novel mutations causing blood stream infections (BSI) in India

Abstract Background Coagulase-negative Staphylococci (CoNS) have emerged as a major causative agent of blood-stream infections (BSI). Linezolid (LZD) is currently used for treating glycopeptide and methicillin-resistant staphylococci. It is important to understand the resistance mechanism and probab...

Full description

Bibliographic Details
Main Authors: Gajanand Mittal, Vasundhra Bhandari, Rajni Gaind, Vandana Rani, Shimpi Chopra, Reetika Dawar, Raman Sardana, P. K. Verma
Format: Article
Language:English
Published: BMC 2019-08-01
Series:BMC Infectious Diseases
Subjects:
Novel mutation
Linezolid resistance
CoNS
cfr
S. arlettae
India
Online Access:http://link.springer.com/article/10.1186/s12879-019-4368-6

Internet

http://link.springer.com/article/10.1186/s12879-019-4368-6

Similar Items